Tasly Pharmaceutical Group Co., Ltd (600535.SS)
CNY 14.7
(0.75%)
CNY 14.7
(0.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 8.54 Billion | 8.59 Billion | 7.95 Billion | 13.57 Billion | 18.99 Billion | 17.98 Billion |
| Cost of Revenue | 2.88 Billion | 3.08 Billion | 2.67 Billion | 8.05 Billion | 13.05 Billion | 11.47 Billion |
| Gross Profit | 5.66 Billion | 5.5 Billion | 5.27 Billion | 5.52 Billion | 5.94 Billion | 6.51 Billion |
| Operating Expenses | 4.56 Billion | 4.12 Billion | 3.96 Billion | 3.98 Billion | 3.94 Billion | 4.06 Billion |
| Selling, General and Administrative Expenses | 3.26 Billion | 2.98 Billion | 3.07 Billion | 2.95 Billion | 3.04 Billion | 3.04 Billion |
| Research and Development Expenses | 917.26 Million | 844.23 Million | 579.52 Million | 689.33 Million | 551.22 Million | 588.88 Million |
| Other Expenses | 309.54 Million | 302.95 Million | 311.36 Million | 346.22 Million | 355.58 Million | 9.82 Million |
| Cost and Expenses | 7.44 Billion | 7.21 Billion | 6.63 Billion | 12.04 Billion | 17 Billion | 15.53 Billion |
| Operating Income | 1.22 Billion | 1.27 Billion | 2.73 Billion | 1.47 Billion | 1.83 Billion | 1.94 Billion |
| Interest Expense | 87.25 Million | 64.41 Million | 77.39 Million | 286.69 Million | 451.07 Million | 487.2 Million |
| Income Tax Expense | 204.45 Million | 180.3 Million | 315.92 Million | 367.19 Million | 327.63 Million | 363.95 Million |
| Earnings before Tax | 1.22 Billion | -160.46 Million | 2.72 Billion | 1.45 Billion | 1.33 Billion | 1.95 Billion |
| Net Income | 1.07 Billion | -340.76 Million | 2.35 Billion | 1.12 Billion | 1 Billion | 1.54 Billion |
| Earnings Per Share Basic | 0.72 | -0.23 | 1.57 | 0.75 | 0.66 | 1.02 |
| Earnings Per Share Diluted | 0.72 | -0.23 | 1.57 | 0.75 | 0.66 | 1.02 |
| Weighted Average Shares Outstanding | 1.48 Billion | 1.49 Billion | 1.5 Billion | 1.5 Billion | 1.5 Billion | 1.5 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.49 Billion | 1.49 Billion | 1.5 Billion | 1.5 Billion | 1.5 Billion | 1.51 Billion |
| Gross Margin | 0.66 | 0.64 | 0.66 | 0.41 | 0.31 | 0.36 |
| EBIT Margin | 0.23 | 0.21 | 0.45 | 0.18 | 0.12 | 0.16 |
| Profit Margin | 0.13 | -0.04 | 0.30 | 0.08 | 0.05 | 0.09 |
| EBITDA | 1.95 Billion | 448.25 Million | 3.42 Billion | 2.34 Billion | 2.22 Billion | 2.8 Billion |
| Earnings Before Tax Margin | 0.14 | 0.15 | 0.34 | 0.11 | 0.10 | 0.11 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.09 Billion | 2.28 Billion | 2.02 Billion | 8.54 Billion | 2.06 Billion | 2.17 Billion |
| Cost of Revenue | 722.93 Million | 793.27 Million | 672.67 Million | 3.06 Billion | 751.02 Million | 692.91 Million |
| Gross Profit | 1.36 Billion | 1.49 Billion | 1.34 Billion | 5.48 Billion | 1.31 Billion | 1.48 Billion |
| Operating Expenses | 1.04 Billion | 981.04 Million | 967.24 Million | 4.04 Billion | 1.18 Billion | 1.04 Billion |
| Selling, General and Administrative Expenses | 1.32 Billion | 838.29 Million | 768.59 Million | - | 851.86 Million | 940.17 Million |
| Research and Development Expenses | 194.4 Million | 143.27 Million | 199.38 Million | - | 329.55 Million | 206.65 Million |
| Other Expenses | -474.37 Million | 524.74 Thousand | 736.45 Thousand | 25.56 Million | -7.93 Million | -1.81 Million |
| Cost and Expenses | 1.76 Billion | 1.77 Billion | 1.63 Billion | 7.1 Billion | 1.94 Billion | 1.73 Billion |
| Operating Income | 204.5 Million | 512.38 Million | 382.17 Million | 1.43 Billion | 125.75 Million | 377.24 Million |
| Interest Expense | 10.14 Million | 19.81 Million | 30.25 Million | 82.52 Million | 15.6 Million | 18.75 Million |
| Income Tax Expense | 28.88 Million | 58.13 Million | 81.4 Million | 204.45 Million | 683.65 Thousand | 61.92 Million |
| Earnings before Tax | 204.02 Million | 455.52 Million | 388.33 Million | 1.35 Billion | 82.8 Million | 375.42 Million |
| Net Income | 179.89 Million | 367.09 Million | 295.21 Million | 1.07 Billion | 38.64 Million | 325.32 Million |
| Earnings Per Share Basic | 0.12 | 0.25 | 0.20 | - | 0.03 | 0.22 |
| Earnings Per Share Diluted | 0.12 | 0.25 | 0.20 | - | 0.03 | 0.22 |
| Weighted Average Shares Outstanding | 1.49 Billion | 1.49 Billion | 1.49 Billion | 1.49 Billion | 1.49 Billion | 1.49 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.49 Billion | 1.49 Billion | 1.49 Billion | 1.49 Billion | 1.49 Billion | 1.49 Billion |
| Gross Margin | 0.65 | 0.65 | 0.67 | 0.64 | 0.64 | 0.68 |
| EBIT Margin | 0.10 | 0.28 | 0.20 | - | 0.12 | 0.21 |
| Profit Margin | 0.09 | 0.16 | 0.15 | 0.13 | 0.02 | 0.15 |
| EBITDA | 214.16 Million | 639.33 Million | 410.76 Million | - | 254.37 Million | 447.16 Million |
| Earnings Before Tax Margin | 0.10 | 0.22 | 0.19 | 0.17 | 0.06 | 0.17 |
SHEL
603158
600398
0OJJ
ATUS
001525